JAN 10,
2014
It has been one year since products distributed by the New England Compounding
Center (NECC) were linked to over 700 cases of fungal meningitis and the deaths
of over 50 patients. Since that outbreak, FDA has responded aggressively,
conducting inspections of almost 70 pharmacies engaged in large-scale
compounding and distribution of sterile products
continue to read here
No comments:
Post a Comment